Mackenzie Financial Corp Takes $478,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Mackenzie Financial Corp purchased a new position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 22,749 shares of the company's stock, valued at approximately $478,000. Mackenzie Financial Corp owned approximately 0.06% of Phibro Animal Health at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in PAHC. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Phibro Animal Health in the fourth quarter worth about $29,000. Lazard Asset Management LLC increased its stake in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after acquiring an additional 1,589 shares during the last quarter. Aquatic Capital Management LLC purchased a new stake in shares of Phibro Animal Health during the 4th quarter worth approximately $69,000. Virtus Fund Advisers LLC bought a new position in shares of Phibro Animal Health during the 4th quarter valued at approximately $69,000. Finally, Quantbot Technologies LP grew its holdings in shares of Phibro Animal Health by 65.1% in the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock valued at $107,000 after purchasing an additional 2,018 shares in the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on PAHC. Barclays raised their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Finally, Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Phibro Animal Health presently has an average rating of "Hold" and a consensus price target of $20.00.

Phibro Animal Health Stock Performance

PAHC stock traded down $0.08 during trading on Thursday, reaching $23.89. The company had a trading volume of 199,585 shares, compared to its average volume of 203,002. The company has a market cap of $968.36 million, a price-to-earnings ratio of 49.77, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The firm has a 50-day simple moving average of $20.69 and a 200-day simple moving average of $21.88.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The firm had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. As a group, sell-side analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.01%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.